HF
TGAN

HRT Financial’s Transphorm, Inc. Common Stock TGAN Stock Holding History

HRT Financial’s Portfolio TGAN Stock Details TGAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,251
Closed -$41K – 3306
2023
Q4 		$41K Buy
+11,251
New +$30.8K ﹤0.01% 1974
2022
Q2 		– Sell
-13,606
Closed -$96K – 3930
2022
Q1 		$96K Buy
+13,606
New +$95.6K ﹤0.01% 2671

Other funds holding TGAN

KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's TGAN Position: Q1 2024 in Review

HRT Financial sold out of Transphorm, Inc. Common Stock (TGAN) in Q1 2024, closing a stake of 11,251 shares — an estimated $41K sold.

HRT Financial first reported a position in TGAN in Q1 2022 and held it in 2 quarters. The position peaked at $96K in Q1 2022. 57 funds tracked by Wall St. Rank hold TGAN as of Q1 2024.

  • HRT Financial reported no remaining Transphorm, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • HRT Financial sold 11,251 Transphorm, Inc. Common Stock shares in Q1 2024, an estimated $41K.
  • HRT Financial first reported a position in Transphorm, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • HRT Financial's Transphorm, Inc. Common Stock position peaked at $96K in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.